Interestingly, increased levels of GPNMB have been observed in brain samples and/or the cerebrospinal fluid of patients with neurodegenerative diseases such as amyotrophic lateral sclerosis, Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis [24,26,27,28]. This evidence concerns the gene GPNMB and amyotrophic lateral sclerosis.